Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus
Human respiratory syncytial virus (hRSV) remains a leading cause of morbidity and mortality in infants, young children, and older adults. hRSV infection's limited treatment and vaccine options significantly increase bronchiolitis' morbidity rates. The severity and outcome of viral infectio...
Saved in:
| Main Author: | Abayeneh Girma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Virus Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S016817022400176X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization
by: Bing Cai, et al.
Published: (2024-11-01) -
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
by: Matteo Riccò, et al.
Published: (2024-11-01) -
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children
by: Z Dangor, et al.
Published: (2024-11-01) -
Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01)